A Study to Compare PK, PD and Safety of the AD-213-A and AD-2131

Clinical trial NCT04690868 · COMPLETED

Trial details

NCT number: NCT04690868
Sponsor: Addpharma Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Gastroesophagus Reflux Disease

Start date: 2021-10-15
Primary completion: 2021-12-11
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.